AHRQ Panel Urged To Support Medicare Coverage Of IDE Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
Clinical trials approved by FDA under investigational device exemptions should be able to self-certify for Medicare coverage, AdvaMed recommended Nov. 20 before a multi-agency panel convened by the Agency for Healthcare Research and Quality.